Mutations Position Table

APOE T11 Mutations

Tools

Back to the Top
Mutation Clinical
Phenotype Studied
DNA Change Expected RNA | Protein Consequence Coding/Non-Coding Genomic Region Biological Effect Primary
Papers
T11A
Hyperlipoproteinemia Type IIb Substitution Substitution | Missense Coding Exon 2

Unknown, but predicted benign in silico (PHRED-scaled CADD = 0.3).

Abou Khalil et al., 2022
T11S
Alzheimer's Disease, Blood Lipids/Lipoproteins, Dementia Substitution Substitution | Missense Coding Exon 2

Unknown, but predicted benign in silico (PHRED-scaled CADD = 0.6).

Rasmussen et al., 2020

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.